- tremors / IMPC
- decreased exploration in new environment / IMPC
- decreased mean corpuscular volume / IMPC
- increased circulating serum albumin level / IMPC
- decreased lean body mass / IMPC
- increased total body fat amount / IMPC
- increased circulating fructosamine level / IMPC
- decreased bone mineral content / IMPC
- preweaning lethality, incomplete penetrance / IMPC
C57BL/6N-F2tm1b(EUCOMM)Hmgu/H
| Status | Only small colony available |
| EMMA ID | EM:16327 |
| Citation information | RRID:IMSR_EM:16327 Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information. |
| International strain name | C57BL/6N-F2tm1b(EUCOMM)Hmgu/H |
| Alternative name | HEPD0720_4_G11 |
| Strain type | Targeted Mutant Strains |
| Allele/Transgene symbol | F2tm1b(EUCOMM)Hmgu |
| Gene/Transgene symbol | F2 |
| Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
| Provider | Mary Lyon Centre at MRC Harwell |
| Provider affiliation | Mary Lyon Centre at MRC Harwell |
| Genetic information | This mouse line originates from EUCOMM ES clone HEPD0720_4_G11. For further details on the construction of this clone see the page at the IMPC portal. The critical exon(s) were flanked by loxP sites, and subsequent cre expression excised this critical sequence resulting in a knockout reporter allele. Click here for more information on EUCOMM final vectors. |
| Phenotypic information | Potential phenotyping data in the IMPC portal |
| References | None available |
Information from EMMA
| Archiving centre | Mary Lyon Centre at MRC Harwell, Oxford, United Kingdom |
Disease and phenotype information
IMPC phenotypes (allele matching)
IMPC phenotypes (gene matching)
- decreased bone mineral content / IMPC
- increased total body fat amount / IMPC
- decreased exploration in new environment / IMPC
- increased circulating fructosamine level / IMPC
- tremors / IMPC
- decreased lean body mass / IMPC
- decreased mean corpuscular volume / IMPC
- preweaning lethality, incomplete penetrance / IMPC
- increased circulating serum albumin level / IMPC
MGI phenotypes (gene matching)
- distended pericardium / MGI
- decreased embryo size / MGI
- abnormal visceral yolk sac morphology / MGI
- pale yolk sac / MGI
- embryonic growth arrest / MGI
- hemorrhage / MGI
- intracranial hemorrhage / MGI
- no abnormal phenotype detected / MGI
- abnormal blood coagulation / MGI
- abnormal vitelline vasculature morphology / MGI
- decreased susceptibility to induced arthritis / MGI
- pallor / MGI
- hemopericardium / MGI
- homeostasis/metabolism phenotype / MGI
- abnormal circulating protein level / MGI
- increased bleeding time / MGI
- decreased susceptibility to endotoxin shock / MGI
- decreased platelet aggregation / MGI
- lethality, incomplete penetrance / MGI
- postnatal lethality, complete penetrance / MGI
- neonatal lethality, complete penetrance / MGI
- embryonic lethality, incomplete penetrance / MGI
- embryonic lethality during organogenesis, incomplete penetrance / MGI
- lethality throughout fetal growth and development, incomplete penetrance / MGI
- purpura / MGI
- embryo tissue necrosis / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).
